Answers are grounded in this paper and cite their sources.
Extracellular vesicles, including microvesicles, exosomes and apoptotic bodies are recognized as carriers of pathogen-associated molecules with direct involvement in immune signaling and inflammation. Those observations have enforced the way these membranous vesicles are being considered as promising immunotherapeutic targets. In this review, we discuss the emerging roles of extracellular vesicles in autoimmunity and highlights their potential use as disease biomarkers as well as targets for the treatment and prevention of autoimmune diseases.
No takes yet. Share an insight, caveat, or question.
Stergios Katsiougiannis (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: